Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is confirmed...
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I believe you are incorrect again. From the press release

"EP'730 is the European counterpart of the basic MMP Portfolio application filed in 1989, which resulted in seven issued U.S. patents."

Essentially the 749 patent was a single patent when it was submitted to the USPTO before it was split up. In Europe it was not split up 7 ways. Please call PTSC before you say it is "confirmed". This is akin to shooting oneself in the foot.

11 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply